Needham Maintains Buy on Boston Scientific, Lowers Price Target to $60
Portfolio Pulse from Benzinga Newsdesk
Needham analyst Mike Matson has maintained a 'Buy' rating on Boston Scientific (NYSE:BSX) but lowered the price target from $65 to $60.
October 27, 2023 | 8:09 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Boston Scientific's price target has been lowered from $65 to $60 by Needham, though the 'Buy' rating is maintained.
The lowering of the price target by Needham could potentially create a negative sentiment among investors. However, the maintained 'Buy' rating indicates that the analyst still sees potential in the stock. This could lead to a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100